{"title":"为什么有些青少年可能需要长效注射剂","authors":"Alison Knopf","doi":"10.1002/cbl.30867","DOIUrl":null,"url":null,"abstract":"<p>The Food and Drug Administration (FDA) has not approved long-acting injectable (LAI) antipsychotic medications for patients under age 18, but researchers have found that for some teens, prescribing these medications off-label is helpful. This is particularly true in teens with bipolar disorder who forget or don't want to take their oral medications, according to the researchers, who found that the LAI antipsychotics were effective, and recommend more FDA trials.</p>","PeriodicalId":101223,"journal":{"name":"The Brown University Child and Adolescent Behavior Letter","volume":"41 5","pages":"5-6"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Why some teens may need long-acting injectables\",\"authors\":\"Alison Knopf\",\"doi\":\"10.1002/cbl.30867\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The Food and Drug Administration (FDA) has not approved long-acting injectable (LAI) antipsychotic medications for patients under age 18, but researchers have found that for some teens, prescribing these medications off-label is helpful. This is particularly true in teens with bipolar disorder who forget or don't want to take their oral medications, according to the researchers, who found that the LAI antipsychotics were effective, and recommend more FDA trials.</p>\",\"PeriodicalId\":101223,\"journal\":{\"name\":\"The Brown University Child and Adolescent Behavior Letter\",\"volume\":\"41 5\",\"pages\":\"5-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Child and Adolescent Behavior Letter\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cbl.30867\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Child and Adolescent Behavior Letter","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cbl.30867","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Food and Drug Administration (FDA) has not approved long-acting injectable (LAI) antipsychotic medications for patients under age 18, but researchers have found that for some teens, prescribing these medications off-label is helpful. This is particularly true in teens with bipolar disorder who forget or don't want to take their oral medications, according to the researchers, who found that the LAI antipsychotics were effective, and recommend more FDA trials.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
